The Quality Metrics Wave 2 Report has been published!
ISPE, in cooperation with McKinsey and Company and 21 participating companies, designed and undertook an extensive Pilot Program from 2014 – 2016 to test the feasibility of collecting and reporting a standardized set of quality metrics. The ISPE Quality Metrics Pilot Program Wave 2 Report provides a further understanding of the relationships first reported in the ISPE Quality Metrics Pilot Wave 1 Report. In the Wave 2 pilot:
During the planning of the Wave 2 pilot, the USFDA issued its “Request for Quality Metrics” FRN and Draft Guidance. The Wave 2 pilot was adjusted to include:
The ISPE Quality Metrics Pilot Program Wave 2 Report provides an in-depth understanding of:
Download the Quality Metrics Wave 2 Report today!
Just Published! Pharma Records and Data Integrity GAMP Guide
Thursday, 20 Apr 2017 10.04
Meet Jazz Pharmaceuticals – 2017 FOYA Project Execution Category Winner
Wednesday, 19 Apr 2017 11.04
Designing Approaches to Pharma Facility & Lifecycle Management
Tuesday, 18 Apr 2017 08.04